Mivtachim The Workers Social Insurance Fund’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mivtachim The Workers Social Insurance Fund’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Sell	65,306 -65,000	-50%	-$8.79M	1.36%	25
2026 Q1	$16.6M	Buy	130,306 +65,306	+100%	+$8.15M	2.11%	16
2025 Q4	$7.93M	Buy	+65,000	New	+$7.45M	1.1%	21
2024 Q2	–	Sell	-150,000	Closed	-$14.2M	–	45
2024 Q1	$14.2M	Buy	+150,000	New	+$13.9M	1.37%	20

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Mivtachim The Workers Social Insurance Fund's XBI Position: Q2 2026 in Review

Mivtachim The Workers Social Insurance Fund reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 50% in Q2 2026, selling an estimated $8.79M and leaving 65,306 shares worth $10.3M. The position accounts for 1.36% of the portfolio, ranked #25.

Mivtachim The Workers Social Insurance Fund first reported a position in XBI in Q1 2024 and has held it in 4 quarters since. The position peaked at $16.6M in Q1 2026. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Mivtachim The Workers Social Insurance Fund held 65,306 shares of State Street SPDR S&P Biotech ETF worth $10.3M as of Q2 2026.
Mivtachim The Workers Social Insurance Fund sold 65,000 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $8.79M.
State Street SPDR S&P Biotech ETF made up 1.36% of Mivtachim The Workers Social Insurance Fund's portfolio in Q2 2026, its #25 holding.
Mivtachim The Workers Social Insurance Fund first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 4 quarters since.
Mivtachim The Workers Social Insurance Fund's State Street SPDR S&P Biotech ETF position peaked at $16.6M in Q1 2026.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Mivtachim The Workers Social Insurance Fund's 13F filing for Q2 2026, filed 6 Aug 2026.